According to a new Ivermectin study published in the Cuerus Journal of Medical Science, the drug reduced the COVID-19 mortality rate by 92 percent.
According to a recent peer-reviewed study, regular ivermectin users had a death rate that was 84 percent lower than that of irregular users and 92 percent lower than that of non-users.
Flávio Cadegiani, a board-certified endocrinologist, and Pierre Kory, a controversial expert in pulmonary and critical care medicine and president and chief executive officer of the Front Line Critical Care Alliance, are among the authors.
The study (pdf below), which was conducted using a prospective observational study of 88,012 participants in the Brazilian city of Itaja, was released on August 31 in the Cuerus Journal of Medical Science.
According to the publication, people who used ivermectin as a preventive medication before becoming infected with COVID experienced significantly lower rates of hospitalisation and mortality.
The cityw...